A Study of QLH2405 in Healthy Participants and Participants With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's Disease

NCT07489599 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

68

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease(AD)
Mild Cognitive Impairment (MCI)

Interventions

DRUG: QLH2405
DRUG: QLH2405
DRUG: Placebo
DRUG: QLH2405
DRUG: Placebo
DRUG: QLH2405
DRUG: Placebo
DRUG: QLH2405
DRUG: Placebo
DRUG: QLH2405
DRUG: Placebo
DRUG: QLH2405
DRUG: Placebo
DRUG: QLH2405
DRUG: Placebo
DRUG: QLH2405
DRUG: Placebo

Sponsor

Qilu Pharmaceutical Co., Ltd.